ESR1 and breast cancer: The reality of BC is complex [2,3,4], with some tumors sensitive to estrogens and expressing ERα and/or ERβ [2] and others expressing HER2, an epithelial growth factor [3], while others are classified as triple-negative BC (TNBC) [4].